Product logins

Find logins to all Clarivate products below.


Orthopedic Biomaterials | Europe | 2016 | Market Analysis

New product releases in the BGS market as well as favorable demographics will continue to drive moderate procedure growth and offset downward pricing pressures in the orthopedic biomaterial market. Nevertheless, economic difficulties, negative publicity for some products, as well as variable reimbursement will remain limiting factors in this space.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic biomaterials in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Physician-Dispensed Cosmeceuticals – Market Insights – Europe
The European physician-dispensed cosmeceutical market will be driven by rising aesthetic consciousness, an aging population, and increasing demand for clinically validated skincare solutions. The…
Report
Spinal Implants – Market Insights – Europe
The European spinal implant market will be characterized by modest growth, driven by demographic trends such as a rapidly aging population and the rising prevalence of spinal disorders. Adoption…
Report
Sports Medicine Devices – Market Insights – Latin America
The Latin American sports medicine device market will see moderate growth, driven by the rise of underpenetrated procedures—such as meniscus repair and ligament reconstruction—alongside the…